Posts in category All News
8% GDP growth not sustainable yet; bond index inclusion may see short-term volatility: Abheek Barua (29-06-2024)
After the inclusion in the JP Morgan global bond index, in the short term. we need to prepare for volatility. But in the long term, the collateral and the second-round benefits are huge, says Abheek Barua. He expects this to lead to an improvement in the fixed-income ecosystem, which unfortunately has not taken off that well
Aditya Vision board to mull stock split proposal (29-06-2024)
Aditya Vision said that its board will meet on Wednesday, 3 July 2024 to consider a proposal of sub- division /split of the equity shares of the company.
Ranvir’s Portfolio (29-06-2024)
Request you to expand a little on Advanced Enzymes. Already holding since Jan 2024.
The company has enormous potential and decent execution, but something is holding it back from becoming lets say the Sun Pharma of Enzyme space (I know it is not a 1-1 comparison but to highlight scale it can do in its space)
Or is it a matter of time and I am not seeing it.
Thanks
Atma Nirbhar Bharat – Stock opportunities (29-06-2024)
check differences in OFS price offered for SJVN, NHPC and others and CMP.
Hot Stocks: 3 stocks that may give returns between 15-31% (29-06-2024)
A look at some of the latest stock recommendations by analysts. These stocks are expected to return between 15% and 31% as per analysts’ price targets.
Neogen Chemicals promoter sells 12.56% stake (29-06-2024)
Kanani sold 14.95 lakh shares at 1,611.14 each. Shares of Neogen Chemicals closed at 1,592.85 on Friday after a decline of 4.76%
Fidelity funds sell Rs 1,788-cr HCL Tech shares (29-06-2024)
ICICI Prudential Mutual Fund was the single largest buyer at 1,001 crore, followed by Morgan Stanley Asia Singapore PTE and Citigroup Global Markets Mauritius fund. Shares of HCL Technologies closed 0.42% up on NSE at 1,461 Friday.
Expect a rally in PSU bank stocks in next few days: Vinit Bolinjkar (29-06-2024)
While IT remains a trading pick, I am cautious due to potential downside risks in the US market affecting IT jobs. Pharma and FMCG are top picks due to the expected resurgence in consumption, likely to drive strong performances over the next quarters.
Stanley Lifestyles lists at 34% premium (29-06-2024)
The IPO consisted of a fresh issue of ₹200 crore and an offer for sale of 91.3 lakh shares aggregating to ₹337 crore on the upper price band. The offer was subscribed 96.98 times on its final day of bidding on June 25.